Up- and Downregulated Genes after Long-Term Muscle Atrophy Induced by Denervation in Mice Detected Using RNA-Seq.

Life (Basel)

Department of Animal and Marine Bioresource Sciences, Graduate School of Agriculture, Kyushu University, Fukuoka 819-0395, Japan.

Published: April 2023

Skeletal muscle atrophy occurs rapidly as a result of inactivity. Although there are many reports on changes in gene expression during the early phase of muscle atrophy, the patterns of up-and downregulated gene expression after long-term and equilibrated muscle atrophy are poorly understood. In this study, we comprehensively examined the changes in gene expression in long-term denervated mouse muscles using RNA-Seq. The murine right sciatic nerve was denervated, and the mice were housed for five weeks. The cross-sectional areas of the hind limb muscles were measured using an X-ray CT system 35 days after denervation. After 28 d of denervation, the cross-sectional area of the muscle decreased to approximately 65% of that of the intact left muscle and reached a plateau. Gene expression in the soleus and extensor digitorum longus (EDL) muscles on the 36th day was analyzed using RNA-Seq and validated using RT-qPCR. RNA-Seq analysis revealed that three genes-, and -were upregulated and one gene--was downregulated in the soleus muscle; additionally, four genes-, , , and -were upregulated and one gene--was downregulated in the EDL muscle (FDR < 0.05). Among these genes, , one of the long non-coding RNAs, was significantly upregulated in both the muscles. These findings indicate that could be a candidate gene for the maintenance of atrophied skeletal muscle size and an atrophic state.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221910PMC
http://dx.doi.org/10.3390/life13051111DOI Listing

Publication Analysis

Top Keywords

muscle atrophy
16
gene expression
16
muscle
9
skeletal muscle
8
changes gene
8
expression long-term
8
genes- -were
8
-were upregulated
8
upregulated gene--was
8
gene--was downregulated
8

Similar Publications

From molecular to physical function: The aging trajectory.

Curr Res Physiol

December 2024

Department of Kinesiology, McMaster University, Hamilton, Ontario, Canada.

Aging is accompanied by a decline in muscle mass, strength, and physical function, a condition known as sarcopenia. Muscle disuse attributed to decreased physical activity, hospitalization, or illness (e.g.

View Article and Find Full Text PDF

Friedreich Ataxia: An (Almost) 30-Year History After Gene Discovery.

Neurol Genet

February 2025

Department of Neurology and Neurosurgery, McGill University, Montreal, Canada.

In the late 1800s, Nikolaus Friedreich first described "degenerative atrophy of the posterior columns of the spinal cord," noting its connection to progressive ataxia, sensory loss, and muscle weakness, now recognized as Friedreich ataxia (FRDA). Renewed interest in the disease in the 1970s and 80s by the Quebec Cooperative Group and by Anita Harding led to the development of clinical diagnostic criteria and insights into associated biochemical abnormalities, although the primary defect remained unknown. In 1988, Susan Chamberlain mapped FRDA's location on chromosome 9.

View Article and Find Full Text PDF

Background: Cancer cachexia represents a debilitating muscle wasting condition that is highly prevalent in gastrointestinal cancers, including pancreatic ductal adenocarcinoma (PDAC). Cachexia is estimated to contribute to ~30% of cancer-related deaths, with deterioration of respiratory muscles suspected to be a key contributor to cachexia-associated morbidity and mortality. In recent studies, we identified fibrotic remodelling of respiratory accessory muscles as a key feature of human PDAC cachexia.

View Article and Find Full Text PDF

An exploratory qualitative assessment of patient and clinician perspectives on patient-reported outcome measures and disease-modifying therapies in adults with spinal muscular atrophy.

J Rehabil Med

January 2025

Stan Cassidy Centre for Rehabilitation, Horizon Health Network, Fredericton, New Brunswick, Canada; Dalhousie Medicine New Brunswick, Dalhousie University, Saint John, New Brunswick, Canada.

Objective: To understand patient, caregiver, and clinician perspectives on patient-reported outcome measures, critical functional domains, and disease-modifying therapies in adult spinal muscular atrophy.

Design: An exploratory qualitative single-site study.

Patients: Ten adults with spinal muscular atrophy and two clinicians participated in semi-structured interviews.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!